In a 30-year-old woman with a morning serum cortisol of 8.6 µg/dL and a plasma ACTH of 5.7 pg/mL, what is the appropriate next diagnostic step and management for possible secondary adrenal insufficiency?

Diagnostic Evaluation and Management

Immediate Interpretation

Your patient's results—morning cortisol 8.6 µg/dL with ACTH 5.7 pg/mL—indicate possible secondary adrenal insufficiency and require confirmatory testing with a cosyntropin stimulation test. 1

The combination of a borderline-low morning cortisol with inappropriately low-normal ACTH is the classic biochemical pattern of secondary (central) adrenal insufficiency, where pituitary ACTH production is deficient. 1, 2 In primary adrenal insufficiency, you would expect ACTH to be markedly elevated (>300 pg/mL) in response to low cortisol. 1

Why This Result Pattern Matters

• Morning cortisol 8.6 µg/dL falls in the indeterminate "gray zone" where adrenal insufficiency cannot be confirmed or excluded without dynamic testing. 1, 3, 4
• A morning cortisol <9 µg/dL (250 nmol/L) with elevated ACTH would be diagnostic of primary adrenal insufficiency, but your patient's ACTH is low, not high. 1, 5
• Morning cortisol >13–14 µg/dL reliably excludes adrenal insufficiency, while <3–5 µg/dL essentially confirms it—your patient is squarely in between. 3, 4
• The low-normal ACTH (5.7 pg/mL) with borderline-low cortisol suggests the pituitary is not appropriately responding to the low cortisol signal, pointing toward secondary adrenal insufficiency. 1, 2

Next Diagnostic Step: Cosyntropin Stimulation Test

Perform the standard high-dose (250 µg) cosyntropin stimulation test to definitively confirm or exclude adrenal insufficiency. 1, 5

Test Protocol

• Administer 0.25 mg (250 µg) cosyntropin (Cortrosyn) intravenously or intramuscularly. 1
• Measure serum cortisol at baseline (time 0) and at exactly 30 minutes post-administration; an optional 60-minute sample can be obtained. 1, 5
• The test can be performed at any time of day and does not require fasting. 1
• Draw a baseline ACTH level before giving cosyntropin if not already obtained, to help distinguish primary from secondary causes. 1

Interpretation Thresholds

• Peak cortisol <18 µg/dL (500 nmol/L) at 30 or 60 minutes confirms adrenal insufficiency. 1, 5, 4
• Peak cortisol >18–20 µg/dL (550 nmol/L) excludes adrenal insufficiency. 1, 5
• Use assay-specific cutoffs if available; some modern assays may have slightly different thresholds. 4

Why High-Dose Over Low-Dose Test

• The 250 µg test is FDA-approved, easier to administer (no bedside dilution required), and has comparable diagnostic accuracy to the 1 µg low-dose test. 1
• The low-dose test requires diluting the commercial preparation, adding complexity without clear diagnostic advantage. 1, 6

Etiologic Workup for Secondary Adrenal Insufficiency

If the cosyntropin test confirms adrenal insufficiency with low ACTH, investigate the underlying cause:

• Obtain pituitary MRI with gadolinium contrast to evaluate for pituitary adenoma, empty sella, hypophysitis, or other structural lesions. 1
• Screen for other pituitary hormone deficiencies: TSH/free T4, LH/FSH, prolactin, and IGF-1 to assess for hypopituitarism. 1, 2
• Review medication history for exogenous glucocorticoids (prednisone, dexamethasone, inhaled fluticasone) that suppress the HPA axis and cause iatrogenic secondary adrenal insufficiency. 1, 6
• Consider history of traumatic brain injury, pituitary surgery, or radiation therapy. 2

Critical Management Considerations

If Clinically Unstable

• Never delay treatment for diagnostic testing if the patient presents with hypotension, altered mental status, severe vomiting, or other signs of adrenal crisis. 1, 5
• Immediately administer 100 mg IV hydrocortisone bolus plus 0.9% saline infusion at 1 L/hour. 1
• Draw blood for cortisol and ACTH before giving hydrocortisone if feasible, but do not wait for results. 1

If Clinically Stable

• The patient can undergo outpatient cosyntropin testing without immediate glucocorticoid replacement. 1
• Educate the patient to seek emergency care if they develop severe vomiting, inability to take oral medications, marked weakness, or confusion before the test is completed. 1

Treatment If Adrenal Insufficiency Is Confirmed

Glucocorticoid Replacement

• Hydrocortisone 15–25 mg daily in divided doses is the preferred regimen: typically 10 mg at 7:00 AM, 5 mg at noon, and 2.5–5 mg at 4:00 PM to mimic physiological cortisol rhythm. 1, 5, 7
• Alternative regimens include cortisone acetate 25–37.5 mg daily or prednisone 4–5 mg daily. 1
• Secondary adrenal insufficiency does not require mineralocorticoid (fludrocortisone) replacement because the renin-angiotensin-aldosterone system remains intact. 1, 2

Mandatory Patient Education

• Stress dosing: Double or triple the usual dose during fever, illness, or physical stress; provide a hydrocortisone 100 mg IM emergency injection kit with self-injection training. 1, 7
• Medical alert identification: The patient must wear a bracelet or necklace indicating adrenal insufficiency to trigger emergency stress-dose steroids by medical personnel. 1, 7
• Perioperative management: Consult endocrinology before any surgery for stress-dose planning (typically hydrocortisone 100 mg IV before anesthesia, then 100 mg IV every 6 hours until oral intake resumes). 1

Special Precaution: Concurrent Hypothyroidism

• If the patient also has hypothyroidism, start glucocorticoid replacement several days before initiating thyroid hormone to prevent precipitating adrenal crisis, as thyroid hormone increases cortisol metabolism. 1, 8

Common Pitfalls to Avoid

• Do not rely on electrolyte abnormalities to make or exclude the diagnosis—hyponatremia occurs in 90% of primary adrenal insufficiency but is less common in secondary adrenal insufficiency; hyperkalemia is absent in secondary adrenal insufficiency because aldosterone production is preserved. 1
• Do not attempt diagnostic testing in patients currently taking exogenous corticosteroids (including prednisone, dexamethasone, or inhaled fluticasone), as these suppress the HPA axis and cause false-positive results. 1, 6
• Do not use dexamethasone for chronic replacement therapy; it lacks mineralocorticoid activity and has a long half-life that prevents mimicking physiological cortisol rhythm. 1
• Do not check morning cortisol levels to monitor adequacy of replacement therapy—dose adjustments should be based on clinical symptoms (fatigue, nausea, weight changes) rather than cortisol measurements. 1, 7

Follow-Up and Monitoring

• Schedule follow-up in 2–4 weeks after initiating replacement therapy to assess symptom response and adjust dosing. 8
• Annual review should include assessment of well-being, weight, blood pressure, and serum electrolytes. 1
• Screen periodically for other autoimmune or pituitary-related conditions if secondary adrenal insufficiency is due to hypopituitarism. 1, 7